Bioage Labs, INC. (BIOA) — 10-Q Filings
All 10-Q filings from Bioage Labs, INC.. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (4)
-
BioAge Narrows Quarterly Loss, Boosts Revenue Amid R&D Spend
— Nov 6, 2025 Risk: high
BioAge Labs, Inc. reported a net loss of $20.17 million for the three months ended September 30, 2025, an improvement from a net loss of $23.41 million in the s -
BioAge Labs Reports No Revenue, Leans on Novartis Collaboration
— Aug 6, 2025 Risk: high
BioAge Labs, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company's net loss for the -
BioAge Labs Files Q1 2025 10-Q
— May 6, 2025 Risk: medium
BioAge Labs, Inc. filed its 10-Q for the period ending March 31, 2025. The company's fiscal year ends on December 31st. Key financial instruments mentioned incl -
BioAge Labs Files Q3 2024 10-Q
— Nov 7, 2024 Risk: medium
BioAge Labs, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial activities and includes information related to its Serie
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX